Clinical Research Directory
Browse clinical research sites, groups, and studies.
An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis
Sponsor: Hoffmann-La Roche
Summary
The study will evaluate the long-term safety and efficacy of Afimkibart (also known as RO7790121) in participants with moderate to severe Rheumatoid Arthritis (RA) who have an inadequate response or intolerance to tumor necrosis factor (TNF) and/or Janus kinase (JAK) inhibitors, and who were previously treated with Afimkibart.
Official title: An Extension Study to Evaluate the Long-term Safety and Efficacy of Afimkibart (RO7790121) in Patients With Rheumatoid Arthritis Who Participated in Previous Afimkibart Clinical Trials
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2026-06-03
Completion Date
2033-07-08
Last Updated
2026-07-24
Healthy Volunteers
No
Conditions
Interventions
Afimkibart
Participants will receive Afimkibart as per the schedule mentioned in the protocol.
Locations (6)
West Broward Rheumatology Associates, Inc.
Tamarac, Florida, United States
Accurate Clinical Management LLC
Houston, Texas, United States
DM Clinical Research
Tomball, Texas, United States
Centrum Kliniczno-Badawcze J. Brzezicki, B. Górnikiewicz-Brzezicka Lekarze Spó?ka Partne
Elblag, Poland
Zespol Poradni Specjalistycznych REUMED filia nr 1 Wallenroda
Lublin, Poland
Reumatop Grzegorz Rozumek Karin Pistorius Spolka Jawna
Wroclaw, Poland